The early predictors of ventricular remodeling after myocardial infarction: The role of tumor necrosis factor-alpha;Akut miyokard infarktüsü sonrasι ventriküler yeniden biçimlenme erken belirleyicileri: Tümör nekrozis faktör-alfa'nιn rolü

Anadolu Kardiyoloji Dergisi

Volumn 9, Issue 2, 2009, Pages 84-90

  Bariş Kaya, Ergün ^a   Özer, Necla ^a   Sinan Deveci, Onur ^a   Kepez, Alper ^a   Tülümen, Erol ^a   Aksöyek, Serdar ^a   Atalar, Enver ^a   Övünç, Kenan ^a   Özmen, Ferhan ^a   Özkutlu, Hilmi ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Logistic regression analysis; Myocardial infarction; Predictive value of tests; Tumor necrosis factor alpha; Ventricular remodeling

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEART INFARCTION; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SENSITIVITY AND SPECIFICITY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR REMODELING;

EID: 65549170437     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Glasser SP. The time course of left ventricular remodelling after acute myocardial infarction. Am J Cardiol 1997; 80: 506-7.
2. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 1990; 81: 1161-72.
3. Warner SJC, Libby P. Human vascular smooth muscles: target for and source of tumor necrosis factor. J Immunol 1989; 142: 100-9.
4. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002; 53: 31-47.
5. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. For the Cholesterol And Recurrent Events (CARE) Investigators. Elevation of tumor necrosis factor-a and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101: 2149-53.
6. Gaudron P, Eilles C, Kugler I. Progressive left ventricular dysfunction and remodeling after myocardial infarction: potential mechanisms and early predictors. Circulation 1993; 87: 755-63.
7. Dodge HT, Sandler H, Ballew DW. Use of biplane angiocardiography for the measurement of left ventricular volume in man. Am Heart J 1960; 60: 762-76.
8. Konstam MA, Wynne J, Holman BL. Use of equilibrium (gated) radionuclide ventriculography to quantify left ventricular output in patients with and without left-sided valvular regurgitation. Circulation 1981; 64: 578-85.
9. Schiller NB. Two-dimensional echocardiographic determination of left ventricular volume, systolic function and mass. Circulation 1991; 84: 280-7.
10. Migrino RQ, Young JB, Ellis SG. End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. Circulation 1997; 96: 116-21.
11. White HD, Norris RM, Brown MA. Left ventricular end systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987; 76: 44-51.
12. Petersen CL, Gadsboll N, Stadeager C. Changes in left and right ventricular performance and volumes in seven-year survivors of acute myocardial infarction. Am J Cardiol 1995; 75: 659-64.
13. Hole T, Vegsundvåg JA, Morstol TH, Skjaerpe T. Early changes in left ventricular volume and function are predictors for long-term remodeling in patients with acute transmural myocardial infarction and preserved systolic function. J Am Soc Echocardiogr 2003; 16: 630-7.
14. Touchstone DA, Beller GA, Nygard TW, Tedesco C, Kaul S. Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: a tomographic assessment using two-dimensional echocardiography. J Am Coll Cardiol 1989; 13: 1506-13.
15. Pirolo JS, Hutchins GM, Moore GW. Infarct expansion: pathologic analysis of 204 patients with a single myocardial infarct. J Am Coll Cardiol 1989; 14: 1149-58.
16. Golia G, Marino P, Rametta F. Reperfusion reduces left ventricular dilation by preventing infarct expansion in the acute and chronic phases of myocardial infarction. Am Heart J 1994; 127: 499-509.
17. Bolognese L, Cerisano G, Buonamici P. Influence of infarct zone viability on left ventricular remodelling after acute myocardial infarction. Circulation 1997; 96: 3353-9.
18. Wu KC, Zerhouni EA, Judd RM. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998; 97: 765-72.
19. Udelson JE, Patten RD, Konstam MA. New concepts in postinfarction ventricular remodelling. Rev Cardiovasc Med 2003; 4: 3-12.
20. Jacobs M, Staufenberger S, Gergs U, Meuter K, Brandstatter K, Hafner M, et al. Tumor necrosis factor-a at acute myocardial infarction in rats and effects on cardiac fibroblasts. J Mol Cell Cardiol 1999; 31: 1949-59.
21. Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Yan A, et al. Tissue expression and immunolocalization of tumor necrosis factor-α in postinfarction dysfunctional myocardium. Circulation 1999; 99: 1492-8.
22. Flesch M, Höper A, Dell'Italia L, Evans K, Bond R, Peshock R, et al. Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor. Circulation 2003; 108: 598-604.
23. Heba G, Krzeminski T, Porc M, Grzyb J, Dembinska-Kiec A. Relation between expression of TNF alpha, iNOS, VEGF, mRNA and development of heart failure after experimental myocardial infarction in rats. J Physiol Pharmacol 2001; 52: 39-52.
24. Berry MF, Woo YJ, Pirolli TJ, Bish LT, Moise MA, Burdick JW, et al. Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodelling. J Heart Lung Transplant 2004; 23: 1061-8.